Last updated: April 24, 2026

Application No. 19/392,245

Untitled Application

Unknown

Filed

1600

Examiner

JONES, DAMERON LEVEST

Art Unit

1618

Tech Center

3B PHARMACEUTICALS GMBH

Assignee

3B Pharmaceuticals GmbH

OA Round

1 (Non-Final)

Interview Optional

— +31.4% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 1068 resolved cases, 2023–2026

Examiner Intelligence

JONES, DAMERON LEVEST View full profile →

Grants 68% — above average

Career Allow Rate

721 granted / 1068 resolved

+7.5% vs TC avg

Strong +31% interview lift

Without

With

+31.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 7m

Avg Prosecution

45 currently pending

Career history

1113

Total Applications

across all art units

Statute-Specific Performance

§101

0.3%

-39.7% vs TC avg

§103

28.7%

-11.3% vs TC avg

§102

5.5%

-34.5% vs TC avg

§112

25.8%

-14.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1068 resolved cases

Prosecution Timeline

1600

Application Filed

Apr 06, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

19/028,880

Patent 12605447

STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES

2y 5m to grant Granted Apr 21, 2026

17/596,802

Patent 12599681

FOAMABLE COMPOSITION FOR USE IN SURGICAL DIAGNOSTIC PROCEDURES

2y 5m to grant Granted Apr 14, 2026

17/144,067

Patent 12589171

177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING

2y 5m to grant Granted Mar 31, 2026

17/424,104

Patent 12576168

PEPTIDE PET/SPECT PROBES SPECIFIC TO ONCOPROTEINS IN TUMOR EXTRACELLULAR MATRIX

2y 5m to grant Granted Mar 17, 2026

17/595,751

Patent 12576170

RK POLYPEPTIDE RADIOPHARMACEUTICAL TARGETING HER2 AND PREPARATION METHOD THEREOF

2y 5m to grant Granted Mar 17, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

68%

Grant Probability

99%

With Interview (+31.4%)

3y 7m

Median Time to Grant

Low

PTA Risk

Based on 1068 resolved cases by this examiner. Grant probability derived from career allow rate.